

Nexavar Disappoints in Breast Cancer Study, Bayer Says
Germany’s Bayer, one of the world’s largest phramaceutical companies, has reported some disappointing news about a potential treatment for advanced breast cancer. The firm now says that Nexavar, which is used to treat a wide range of cancers, cannot significantly improve breast cancer patients’ chances of survival. For some time Nexavar (also known as Sorafenib) […]
2 min read